in-stent restenosis

FDA approves AGENT DCB for coronary artery disease patients

Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for the AGENT Drug-Coated Balloon (DCB), which is indicated to treat coronary in-stent restenosis (ISR) in patients with coronary...
- Advertisement -spot_img

Latest News

Each Zodiac Sign’s Weekly Love Horoscope From Now To June 2

To love is to live, and to live is to love. That's the eccentric energy of this week, between...
- Advertisement -spot_img